Pinnacle Holdings’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Pinnacle Holdings’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-109	Closed	-$8.31K	–	256
2023 Q1	$8.31K	Buy	+109	New	+$9.04K	﹤0.01%	241
2022 Q3	–	Sell	-188	Closed	-$14K	–	244
2022 Q2	$14K	Hold	188	–	–	0.01%	211
2022 Q1	$16.9K	Buy	+188	New	+$17.4K	0.01%	222

Other funds holding XBI

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

APF

Alaska Permanent Fund Juneau, Alaska $1.51B AUM 22.23% 1-Year Est. Return

Pinnacle Holdings's XBI Position: Q2 2023 in Review

Pinnacle Holdings sold out of State Street SPDR S&P Biotech ETF (XBI) in Q2 2023, closing a stake of 109 shares — an estimated $8.31K sold.

Pinnacle Holdings first reported a position in XBI in Q1 2022 and held it in 3 quarters. The position peaked at $16.9K in Q1 2022. 712 funds tracked by Wall St. Rank hold XBI as of Q2 2023.

Pinnacle Holdings reported no remaining State Street SPDR S&P Biotech ETF position as of Q2 2023 after selling out during the quarter.
Pinnacle Holdings sold 109 State Street SPDR S&P Biotech ETF shares in Q2 2023, an estimated $8.31K.
Pinnacle Holdings first reported a position in State Street SPDR S&P Biotech ETF in Q1 2022 and held it in 3 quarters.
Pinnacle Holdings's State Street SPDR S&P Biotech ETF position peaked at $16.9K in Q1 2022.
712 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2023.

Based on Pinnacle Holdings's 13F filing for Q2 2023, filed 11 Aug 2023.